Today, the Cognizant platform is used at over 19,000 trial-ready sites by medical and life sciences professionals to reduce administrative burdens that often slow the development and testing of life-saving clinical therapies.A global biopharmaceutical company using the platform realized a 50% reduction in critical site activation cycle time, based on an internal sponsor benchmark study.